 |
|
HER-2/neu intracellular domain protein
The cytoplasmic domain or intracellular domain (ICD) of the HER2/neu protein that exhibits tyrosine kinase activity. Based on sensitization theory, co-administration of trastuzumab (anti-HER-2/neu monoclonal antibody) and HER-2/neu intracellular domain protein may result in the potentiation of a HER2/neu-specific cytotoxic T lymphocyte (CTL) response against tumor cells overexpressing the HER2/neu protein. HER-2/neu protein, a glycoprotein cell surface receptor that is composed of an extracellular domain (ECD), a transmembrane domain, and an ICD, is overexpressed by many adenocarcinomas including breast adenocarcinoma. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | HER-2 ICD Peptide
HER-2/neu ICD Protein | | |
| Previous: | hepatitis A vaccine, hepatitis B vaccine, Hepsera, hepsulfam, HER-2-neu, CEA peptides, GM-CSF, Montanide ISA-51 vaccine | | Next: | HER-2/neu peptide vaccine, herba scutellaria barbata, Herceptin, Herplex, Hexa-Betalin |
|
|
